Dougherty’s Pharmacy Inc. (fka MYDP)

[lowfloatmagic]

$MYDP I was watching this one too, that L2 crazy thin, I hope I can get shares in the .02-.03 range tomorrow

[G-Schmoney]

Agreed, I think the 10 day avg was only 4k? Either way looks like the start of a nice move $MYDP

[AAAAMHIM]

MYDP I wouldn't say the volume was all that nice. It's just UNUSUAL. INCREDIBLE how tiny hits on the asks moves MYDP miles! Shows the significance of a TINY MICROSCOPIC FLOAT. Tomorrow MYDP will close above 7 cents I'm getting the word out. MYDP.


MYDP

[G-Schmoney]

$MYDP nice volume today too, looks like it may have the attention of a few others today as well

[AAAAMHIM]

Agreed chartwise MYDP could hit scanner tonight. I'm excited of bringing her to the masses. MYDP is a life changing kind of stock.
MYDP

[AAAAMHIM]

MYDP agreed. MYDP won't be UNKNOWN for long, only a matter of time. MICROSCOPIC share structure. Only 50 million A/S, 23 million O/S and 578k FLOAT??!! Insane. MYDP. Come join the party my friend you won't be disappointed.

[G-Schmoney]

$MYDP definitely on my list to watch for tomorrow

[G-Schmoney]

Nice pop on the charts today, could be the start of an epic run IMO

[G-Schmoney]

$MYDP I seriously can't believe that a stock like this is still unknown to OTC traders

[AAAAMHIM]

MYDP yes my friend its unheard of. Have you ever seen a stock with a FLOAT this low trading at only 3 cents? Worst thing about it there are only like 2 posts this whole year. MYDP wont be UNKNOWN for long.
MYDP

[G-Schmoney]

Wow, this stock sounds AMAZING! 578k shares in the float?

[AAAAMHIM]

MYDP I AGREE. I hope you're getting some more down here. I'm about to turn her into a household name.

It is THE #1 stock to buy right now, easily 1 of the most undervalued stocks in America. MYDP is under the radar, a high integrity growth and value stock being run with a code of ethics using world class best business practices and governance making it one of the best stock investments for 2019.

MYDP truly is an amazing value stock that come along once in a blue moon, value investing made Warren Buffett one of the best investors! Value investing entails the fundamental analysis of a company's earnings power versus its current share price. Value investing has made Warren Buffett and many of his colleagues famously rich. Not a bad model to emulate, now is the time to buy shares of MYDP imo.
MYDP

[AAAAMHIM]

MYDP is ready folks. MYDP is UNKNOWN but not after I get done with this MICROSCOPIC float BIOTECH gem
MYDP will be a household name soon
MYDP

[swanlinbar]

WTF with You? Reply to a message from 2015 Just come out of a Coma!

[DIVEROTC1]

Huh? Wtf u talking about

[chevdawg18]

Form 4 Filing -- doesnt get more bullish than having the director of the company of a very thinly traded stock buying up all the asks in the open market.

Another 100K purchase being showed on thursday at .1725 and the prior purchases shown in the Form 4 from .09-.12 a few weeks ago.

Hes making bank on his buys so far and im guessing he knows this is going much higher. Pretty cool

And love seeing this board dead while this is happening.

[Werbe]

TA is verified and puts float at 578,000 but I believe its an error. Good bottom play if dilution stays away but god knows.

https://www.otcmarkets.com/stock/MYDP/security

On August 1, 2018, the Company defaulted on its revolving credit facility of $4,000,000 (“the Revolver”) with the First National Bank of Omaha (the “Lender”). On August 10, 2018, the Lender notified the Company that the Revolver had been sold to OSK VII, LLC (the “Current Lender”) effective on August 10, 2018. This assignment of the Revolver from the Lender to the Current Lender does not affect any terms and condition of the Revolver and the associated loan documents. The Company does not currently have the ability to cure the default under the Revolver. Should the Current Lender elect to foreclose against the Secured Assets, it would significantly impair the Company's ability to continue as a going concern or to even be able to continue its operations. The Company is evaluating all of its options in light of these circumstances, including, refinancing the indebtedness with another lender, negotiating a settlement arrangement with the Current Lender, or obtaining a temporary waiver or forbearance from the Current Lender.

[$Pistol Pete$]

$MYDP Ascendant Solutions, Inc. Changes Corporate Name to Dougherty’s Pharmacy, Inc.; Now Trading Under New Ticker Symbol – OTC PINK: MYDP

[Renee]

Effective June 9,2017 Ascendant Solutions Inc., ASDS, will change to Dougherty’s Pharmacy Inc., MYDP:

http://otce.finra.org/DLSymbolNameChanges

[ghmm]

The ask is now .44. Even though that is a big spread from the bid IMO that isn't exactly expensive considering BV, NOL's and if they are really capable of executing on growing the pharmacy business via growing business and acquisition. What we don't know yet is how profitable and what type of synergy/added new revenue they can drive to the new acquisitions. If they do that well this stock is mult-bag potential once people discover it.

[swanlinbar]

Ascendant Solutions, Inc. Announces Completion of Third Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary
12:31p ET January 8, 2015 (PR NewsWire) Print
Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced that its Healthcare subsidiary, Dougherty's Holdings, has acquired McCrory's Pharmacy ("McCrory"), located in El Paso, Texas.

The McCrory acquisition is expected to add approximately $8 million in annual revenues to Ascendant's results. In total, Ascendant's three recent acquisitions (including McCrory's) should boost sales for Dougherty's Holdings 25 percent to over $37 million in 2015, compared to estimated 2014 sales of $29 million.

For more than 56 years, McCrory's Pharmacy has provided retail prescriptions, sterile and non-sterile compounded prescriptions, hormone testing, diabetes support, and home healthcare services and equipment for customers in and around the El Paso area.

Mark Heil, President and CFO of Ascendant, stated, "We are very excited to add McCrory's to our family of Dougherty's Pharmacy locations. Given McCrory's excellent reputation as the premier independent pharmacy in El Paso, we intend to continue to operate this pharmacy under the McCrory's name. As with previous acquisitions, we look forward to expanding McCrory's robust retail and compounding business. McCrory's commitment to service and quality aligns perfectly with Dougherty's Pharmacy in Dallas, where we have provided health care services for our customers for almost a century."

About Dougherty's Pharmacy

Dougherty's Pharmacy has been the premier pharmacy in Dallas since 1929, offering a wide variety of products and services to customers, including prescriptions, compounds, durable medical equipment, nutritional products, diabetic supplies and a host of other health and wellness products and services.

About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value-oriented investment firm focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Ascendant at OTCMarkets.com or at www.ascendantsolutions.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's current expectations, projections, estimates and assumptions. These forward-looking statements may be identified by words such as "expects," "believes," "anticipates" and similar expressions. Forward-looking statements involve risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ascendant-solutions-inc-announces-completion-of-third-pharmacy-acquisition-by-its-doughertys-holdings-subsidiary-300017939.html

SOURCE Ascendant Solutions, Inc.

[swanlinbar]

ASDS a dollar doesn't seem that far off now!

[bobkubecka]

Doesn't make much sense to me either

[nsomniyak]

Thanks for the info. However a 1% stock dividend is dumb.

[bobkubecka]

This from the daily list today, looks like a 1% stock divy
http://otce.finra.org/DailyList
Summary
Date Event Type Eff/Ex Date Symbol Issue Name Market
11/21/2014 Stock Dividend Special 12/1/2014 ASDS Ascendant Solutions, Inc. Common Stock Other OTC
Details
Previous Value Current Value
Symbol ASDS ASDS
Issue Name Ascendant Solutions, Inc. Common Stock Ascendant Solutions, Inc. Common Stock
Class
Financial Status Indicator
Market Category Other OTC Other OTC
Current Value
Daily List Date 11/21/2014 00:00:00
Event Type Stock Dividend Special
Effective/Execution (Eff/Ex) Date 12/1/2014
Subject to Corporate Action
Offering Type No Restrictions
Forward Split Ratio
Reverse Split Ratio
Dividend Type Stock Dividend
Percentage 1
Cash Amount 0
Declaration Date 12/10/2014
Record Date 12/3/2014
Payment Date 12/10/2014
Payment Method
Qualified Dividend Code Unknown
Daily List Comment

[blindman28]

looks like the companies plan with the hiring of the IR firm and acquisitions is finally happening. more good news today

[swanlinbar]

Ascendant Solutions, Inc. Reports Second Quarter 2014 Earnings
PR Newswire Ascendant Solutions, Inc.
3 hours ago
DALLAS, Aug. 20, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results for the second quarter of fiscal 2014. The Company reported consolidated net income of $157,000, or $0.01 per share, for the quarter ended June 30, 2014, compared to net income of $271,000, or $0.01 per share, for the same period of 2013. Consolidated net income for the six months ended June 30, 2014 was $222,000, compared to $844,000 for the first six months of 2013, resulting in net income per share of $0.01 compared to $0.03. The 2013 six-month results included one-time gains of $454,000 from the successful sales of its wholly owned subsidiary, FPG Partners, LLC, and Ascendant's 80 percent interest in CRESA Capital Markets Group, L.P.

Common shares outstanding for the quarter ended June 30, 2014 and 2013 were 21,571,510 and 24,447,931, respectively. In September 2013, the Board of Directors approved the cancellation of Ascendant's 2008 Incentive Plan, reducing the Company's common stock outstanding from 24,447,931 to 21,571,510 shares.

For the second quarter ended June 30, 2014, the Company reported Consolidated Earnings (Loss) before Interest, Taxes, Depreciation and Amortization ("EBITDA") of $251,000 compared to consolidated EBITDA of $388,000 in 2013. EBITDA for the six months ended June 30, 2014, was $414,000 compared to $1,082,000 for the same period of 2013. EBITDA from last year's first quarter benefited from the one-time gains mentioned above.

Healthcare

The Company's subsidiary, Dougherty's Holding, Inc. ("DHI"), which owns and operates multiple Dougherty's Pharmacies, reported EBITDA of $418,000 for the second quarter ended June 30, 2014, compared to $460,000 in 2013. EBITDA for the six months ended June 30, 2014, was $724,000 compared to $834,000 for the same period of 2013. Healthcare expenses were higher in the second quarter ended June 30, 2014 due to additional rent expense at both Dougherty's locations as well as planned expenses related to acquisition activity.

Other

Real estate investments reported EBITDA of $12,000 for the second quarter ended June 30, 2014, compared to $13,000 in 2013. Real estate investments EBITDA for the six months ended June 30, 2014, was $22,000 compared to $80,000 in 2013.

The Company's corporate overhead division reported negative EBITDA of ($179,000) for the second quarter of 2014 compared to ($155,000) in 2013. Corporate overhead EBITDA for the six months ended June 30, 2014, was ($332,000) compared to ($288,000) in 2013.

One-time gains in the first and second quarter ended June 30, 2013 were $384,000 and $70,000, respectively.

Management Comments

"Earlier this month, we were pleased to announce our first community pharmacy acquisition through our Dougherty's Holdings subsidiary," said Jim Leslie, Chairman of Ascendant. "Family Pharmacy, located in Lewisville, Texas, has now been combined with our Dougherty's Pharmacy location at Forest Park Medical Center. We continue to pursue additional acquisitions of well-run independent pharmacies in the Southwest, and we believe this targeted growth strategy will strengthen our operations and result in enhanced shareholder value over time."

Mark Heil, President and CFO, added, "The Family acquisition represents the first step in our previously announced growth strategy to build our community pharmacy business. We expect the Family Pharmacy acquisition to add approximately $4 million in annual revenues to Ascendant's results. We're also pleased to be able to offer Family's unique multi-dose compliance packaging system as an alternative for Dougherty's existing customers. We look forward to continuing to enhance the Dougherty's brand with the addition of other well-run independent pharmacy operations."

EBITDA is calculated as net income (loss) before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company's management reviews these non-GAAP financial measures internally to evaluate the Company's performance and manage the operations. Additionally, the Company believes it is a useful metric to evaluate operating performance and has therefore included such measures in the reporting of operating results.





Select Balance Sheet Items and Book Value per Share
(000's omitted, except per share amounts, unaudited)







June 30,

December 31,


2014

2013





Total Current Assets

$ 3,821

$ 4,134
Property and Equipment, net

907

933
Equity Method Investments

5,107

5,107
Deferred Tax Asset

3,000

3,000
Total Assets

$ 12,835

$ 13,174





Total Current Liabilities

$ 1,820

$ 2,783
Notes Payable, Long-Term

2,337

1,939
Total Liabilities

4,157

4,722
Stockholders' Equity

8,678

8,452
Total Liabilities and Equity

$ 12,835

$ 13,174





Common Shares Outstanding

21,571,510

21,571,510
Book Value per Share

$ 0.40

$ 0.39


About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value-oriented investment firm focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Ascendant at OTCMarkets.com or at www.ascendantsolutions.com.

[hweb2]

Seems to be a large buyer again today. Not sure if this is related to the acquisition, or if we'll get a strong earnings report this month. Maybe both. Nice to see whatever the reason!

[hweb2]

Acquisition announced today. Will add $4M to the top line!


Ascendant Solutions, Inc. Announces Completion of First Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary
PR Newswire
Ascendant Solutions, Inc. 1 hour ago

DALLAS, Aug. 5, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced that its Healthcare subsidiary, Dougherty's Holdings, has acquired Family Pharmacy ("Family"), located in Lewisville, Texas and has combined Family's operations with Dougherty's Pharmacy location at Forest Park Medical Center. Since 2012, Family Pharmacy has provided retail prescriptions to its customers primarily by using state-of-the-art automated compliance packaging not found at most retail pharmacies.

The Family acquisition represents the first step in Ascendant's previously announced growth strategy to acquire well-run independent pharmacies, primarily in Texas and the southwestern U.S. Ascendant expects the Family Pharmacy acquisition to add approximately $4 million in annual revenues to Ascendant's results.

Mark Heil, President and CFO of Ascendant, stated, "We are very excited about the acquisition of Family Pharmacy by our subsidiary, Dougherty's Holdings, and we look forward to expanding revenues and service offerings at Dougherty's Forest Park location. This acquisition fits nicely into our strategy of expanding our retail pharmacy business in the Texas region and also allows us to offer Family's unique multi-dose compliance packaging as an alternative for Dougherty's existing customer base.

"We are confident that Family Pharmacy's customers will be pleased with the additional products and services that Dougherty's will be able to offer them while continuing to provide the personalized customer service they have been receiving."

About Dougherty's Pharmacy

Dougherty's Pharmacy has been the premier pharmacy in Dallas since 1929 offering a wide variety of products and services to customers, including prescriptions, compounds, durable medical equipment, nutritional products, diabetic supplies and a host of other health and wellness products and services.

About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value-oriented investment firm focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Ascendant at OTCMarkets.com or at www.ascendantsolutions.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's current expectations, projections, estimates and assumptions. These forward-looking statements may be identified by words such as "expects," "believes," "anticipates" and similar expressions. Forward-looking statements involve risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.

Contacts:





Mark S. Heil


Geralyn DeBusk



President and CFO


Halliburton Investor Relations



972-250-0945


972-458-8000

[blindman28]

what was up with volume here yesterday?

[hweb2]

Nice to see a little volume today. Q1 results were weak, but sounds like Q2 could be much better. Stock sure looks cheap below .20 if that's the case.


CFO quote from 6/4/14 earnings PR:

"Looking at the business today, we believe Ascendant is well-positioned for stronger second quarter results, and we look forward to adding further value to our business."

[stocktrademan]

$ASDS recent news/filings

bullish

## source: finance.yahoo.com

Tue, 17 Jun 2014 17:04:13 GMT ~ ASCENDANT SOLUTIONS INC Financials


read full: http://finance.yahoo.com/q/is?s=asds
*********************************************************

Wed, 04 Jun 2014 15:03:00 GMT ~ Ascendant Solutions, Inc. Reports First Quarter 2014 Earnings

[PR Newswire] - DALLAS, June 4, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results for the first quarter of fiscal 2014. ...

read full: http://finance.yahoo.com/news/ascendant-solutions-inc-reports-first-150300421.html
*********************************************************

Mon, 14 Apr 2014 15:25:00 GMT ~ Ascendant Solutions, Inc. Promotes Mark S. Heil to President and Chief Financial Officer

[PR Newswire] - DALLAS, April 14, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") announced today that Mark S. Heil will assume the role of President and Chief Financial Officer of the Company. Heil has been the Vice President-Finance and Chief Financial Officer of Ascendant and certain of its subsidiaries since 2007. Heil has also been President of Ascendant's healthcare subsidiary, Dougherty's Holdings, Inc., and currently serves on the Board of Directors of Dougherty's Holdings. "I am pleased to announce Mark's promotion to President and Chief Financial Officer of Ascendant," said James C. Leslie, the Company's Chairman of the Board.

read full: http://finance.yahoo.com/news/ascendant-solutions-inc-promotes-mark-152500669.html
*********************************************************

Mon, 03 Mar 2014 20:17:00 GMT ~ Ascendant Solutions, Inc. Reports Fourth Quarter 2013 Earnings

[PR Newswire] - DALLAS, March 3, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results for the fourth quarter of fiscal 2013. ...

read full: http://finance.yahoo.com/news/ascendant-solutions-inc-reports-fourth-201700998.html
*********************************************************

Fri, 15 Nov 2013 18:23:00 GMT ~ Ascendant Solutions, Inc. Reports Third Quarter 2013 Earnings, Earnings per Share and EBITDA

[PR Newswire] - DALLAS, Nov. 15, 2013 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results for the third quarter of fiscal 2013. ...

read full: http://finance.yahoo.com/news/ascendant-solutions-inc-reports-third-182300064.html
*********************************************************


$ASDS charts

basic chart ## source: stockcharts.com



basic chart ## source: eoddata.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$ASDS company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ASDS/company-info
Ticker: $ASDS
OTC Market Place: OTC Pink Current
CIK code: 0001080029
Company name: Ascendant Solutions, Inc.
Company website: http://www.ascendantsolutions.com
Incorporated In: DE, USA

Business Description: Ascendant Solutions, Inc. is a value oriented investment firm focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Ascendant at OTCMarkets.com


$ASDS share structure

## source: otcmarkets.com

Market Value: $3,990,729 a/o Jul 18, 2014
Shares Outstanding: 21,571,510 a/o Mar 31, 2014
Float: 14,744,561 a/o Dec 31, 2013
Authorized Shares: 50,000,000 a/o Mar 31, 2014
Par Value: 0.0001
$ASDS extra dd links

Company name: Ascendant Solutions, Inc.
Company website: http://www.ascendantsolutions.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ASDS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ASDS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ASDS+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/news - http://finance.yahoo.com/q/h?s=ASDS+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ASDS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ASDS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ASDS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Ascendant+Solutions%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Ascendant+Solutions%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Ascendant+Solutions%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ascendantsolutions.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ascendantsolutions.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ascendantsolutions.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ASDS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001080029&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ASDS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ASDS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ASDS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ASDS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ASDS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ASDS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ASDS+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ASDS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ASDS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ASDS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ASDS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ASDS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ASDS/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ASDS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ASDS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ASDS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ASDS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ASDS



$ASDS DD Notes ~ http://www.ddnotesmaker.com/ASDS
gcnd

[hweb2]

Q1 results were mediocre at best. But the good news is the CFO sounds upbeat on Q2 (and there's less than a month left in the quarter):

"Looking at the business today, we believe Ascendant is well-positioned for stronger second quarter results, and we look forward to adding further value to our business."

[Hegotgame]

Ascendant Solutions, Inc. Reports First Quarter 2014 Earnings

Alert
Ascendant Solutions, Inc. (PL) (USOTC:ASDS)
Intraday Stock Chart
Today : Wednesday 4 June 2014.
DALLAS, June 4, 2014 /PRNewswire/ -- Ascendant Solutions, Inc. (Pink Sheets: ASDS) ("Ascendant" or the "Company") today announced its results for the first quarter of fiscal 2014. The Company reported consolidated net income of $65,000, or less than $0.01 per share, for the quarter ended March 31, 2014, compared to net income of $573,000, or $0.02 per share, for the same period of 2013. First quarter 2013 results included a one-time $432,000 gain related to the exit of one of Ascendant's portfolio companies. Common shares outstanding for the quarter ended March 31, 2014 and 2013 were 21,571,510 and 24,447,931, respectively.

For the first quarter ended March 31, 2014, the Company reported Consolidated Earnings (Loss) before Interest, Taxes, Depreciation and Amortization ("EBITDA") of $163,000 compared to consolidated EBITDA of $694,000 in 2013. EBITDA from last year's first quarter benefitted from the $423,000 gain mentioned above.

Healthcare

The Company's subsidiary, Dougherty's Holding, Inc. ("DHI"), which owns and operates multiple Dougherty's Pharmacies, reported EBITDA of $306,000 for the first quarter ended March 31, 2014, compared to $374,000 in 2013.

Other

Real estate investments reported EBITDA of $10,000 for the first quarter ended March 31, 2014, compared to $67,000 in 2013. The Company's corporate overhead division reported negative EBITDA of ($153,000) for the first quarter of 2014 compared to ($133,000) in 2013. EBITDA from discontinued operations was zero for the first quarter ended March 31, 2014 as compared to $386,000 in 2013.

Management Comments

"Overall, our first quarter 2014 results came in close to our expectations, while prior year first quarter 2013 results included a significant gain in our real estate and other division due to the successful exit of one of our portfolio companies," said Jim Leslie, Chairman of Ascendant. "We remain focused on building our healthcare division, as we aggressively pursue growth opportunities through our Dougherty's Holding subsidiary. Through investments in strategic acquisitions and organic expansion, we expect to deliver enhanced shareholder value over time through well-planned growth, solid performance and operational excellence."

Mark Heil, CFO, added, "While the gain in last year's first quarter makes comparative results difficult, we are pleased that our healthcare division continued to produce solid results for the 2014 first quarter. In addition, our Company's balance sheet showed steady improvement with further debt reductions, stockholders' equity rose slightly, and our book value per share remained strong. Looking at the business today, we believe Ascendant is well-positioned for stronger second quarter results, and we look forward to adding further value to our business."

EBITDA is calculated as net income (loss) before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company's management reviews these non-GAAP financial measures internally to evaluate the Company's performance and manage the operations. Additionally, the Company believes it is a useful metric to evaluate operating performance and has therefore included such measures in the reporting of operating results.

Select Balance Sheet Items and Book Value per Share
(000's omitted, except per share amounts, audited)




March 31,


December 31,



2014


2013






Total Current Assets


$ 3,953


$ 4,134

Property and Equipment, net


933


933

Equity Method Investments


5,107


5,107

Deferred Tax Asset


3,000


3,000

Total Assets


$ 12,993


$ 13,174






Total Current Liabilities


$ 2,518


$ 2,783

Notes Payable, Long-Term


1,956


1,939

Total Liabilities


4,474


4,722

Stockholders' Equity


8,519


8,452

Total Liabilities and Equity


$ 12,993


$ 13,174






Common Shares Outstanding


21,571,510


21,571,510

Book Value per Share


$ 0.39


$ 0.39

About Ascendant Solutions, Inc.

Ascendant Solutions, Inc. is a value-oriented investment firm focused on successfully acquiring, managing and growing community-based pharmacies in the Southwest Region. Ascendant currently has approximately $43 million in net operating loss carryforwards which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities. Interested investors can access financials and stock trading information for Ascendant at OTCMarkets.com or at www.ascendantsolutions.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Securities Act of 1933, the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's current expectations, projections, estimates and assumptions. These forward-looking statements may be identified by words such as "expects," "believes," "anticipates" and similar expressions. Forward-looking statements involve risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.

SOURCE Ascendant Solutions, Inc.


Copyright 2014 PR Newswire

[blindman28]

IR said in an email sometime next week or so

[hweb2]

Prepare to be disappointed. Company is already pretty late with the filing, so why would you be confident today is the day? Wouldn't expect much from the numbers anyway. There was a real estate gain in Q1 last year. So earnings prob .01 vs. .02 last year.

[blindman28]

will be kinda of disappointed if the Q is not filed today

[blindman28]

your probably right……… although i have slight hope with this new IR firm

[otcbargains]

Unfortunately it probably wont help. A good 10q will result in nothing A bad 10Q will create a sell off. Maybe this time will be different.

[blindman28]

guessing 10-Q will be out on friday

[blindman28]

interesting price action today. Someone dropped the ask to .205 and it was bought up within seconds….. im guessing we will get Q results on the 30th

[otcbargains]

Yeah could be something big coming. Maybe.

[blindman28]

hey OTC does it still baffle you why ASDS hire a huged IR firm back in mid march? I mean if you are planning on staying a small company you do not need to hire an IR firm of that size

[blindman28]

CVS Walgreens and Rite aid all had good quarters for their pharmacy sector i hope that has a trickle down affect for ASDS

[blindman28]

probably just retail then no reason to get excited

[otcbargains]

Nite is top bidder. Csti with larger bid just below.

[blindman28]

which MM is on the bid right now?

[blindman28]

wow buying at the ask today it is a miracle

[dffhogs]

Notice of annual meeting.

http://ascendantsolutions.com/Financial_Results

[blindman28]

i really did fall for that investor relations firm trap. The other Clients they had besides ASDS were so great i thought something big was going to happen for ASDS